Abiopharma

CBL Properties Announces Significant New Leasing Activity at West County Center in St. Louis, Missouri

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Sleep Number Corporation (NASDAQ: SNBR)

Clinical trial NCT00238628 updates: 1. enrollment: 12 → 6 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05415137 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-08-31 → 2025-07-14 3. primary completion date: 2025-07-31 → 2025-06-25

Clinical trial NCT06849791 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-01 → 2026-05-08 3. primary completion date: 2026-03-01 → 2026-05-08

Clinical trial NCT07403968: start date: 2026-05-16 → 2026-06-15.

Clinical trial NCT05922371 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-03-01 → 2025-07-04 3. primary completion date: 2025-02-01 → 2025-07-04 4. enrollment: 500 → 34 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06492707: status: SUSPENDED → RECRUITING.

Clinical trial NCT05404139 updates: 1. completion date: 2026-03-01 → 2031-02-01 2. primary completion date: 2026-03-01 → 2031-02-01

Clinical trial NCT04516369 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-22 → 2026-05-19